October 16, 2025

New Criteria, New Numbers on Obesity

A Lancet Commission definition integrating BMI with anthropometric measures increased obesity prevalence by ~60% in a major US cohort, identifying previously unrecognized high-risk patients while introducing distinct clinical phenotypes.

Conexiant

October 16, 2025

Needles and Pills: Painless Oral Protein Delivery

Researchers at the University of Bath are bringing the vision of pills as an alternative to injections for life-saving biologics closer to reality.

The Medicine Maker

October 15, 2025

Study Describes Patterns in Reported Drug Interactions

Researchers analyze about 177,000 drug interactions to identify key medication safety trends.

Conexiant

October 15, 2025

‘Covered.’ ‘Authorized.’ Prescribed? 

'Covered,’ yes. But who’s actually getting GLP-1s—and why so few scripts?

KFF Health News

October 08, 2025

New Data Tie GLP-1 Therapies to GERD

"These potential risks should be weighed against the established clinical benefits of this drug class."

Conexiant

September 29, 2025

Clinicians: Ultraprocessed Food Limits Coming to Cafeterias?

States consider bipartisan bans on ultraprocessed foods in schools over obesity and child health.

KFF Health News

September 29, 2025

ACC Calls for Universal Inflammation Screening

New scientific statement positions hsCRP testing alongside cholesterol as evidence mounts for targeting residual inflammatory risk. 

Conexiant

September 29, 2025

Genetic Study: Fat Sites May Influence Cancer

Researchers examine how body fat distribution may influence risks across 12 cancer types.

Conexiant

September 29, 2025

Oral Semaglutide Cuts Weight in Patients With Obesity

Oral semaglutide 25 mg improves weight, metabolic measures, and physical function in patients.

Conexiant